Effect of a Higher-Protein Nut versus Higher-Carbohydrate Cereal Enriched Diet on the Gut Microbiomes of Chinese Participants with Overweight and Normoglycaemia or Prediabetes in the Tū Ora Study.
Saif FarajIvana Roosevelt SequeiraLouise LuJennifer Lynn Miles-ChanMichael HoggardDaniel BarnettAmber Parry-StrongMeika FosterJeremy D KrebsSally D PoppittMichael W TaylorAkarsh MathraniPublished in: Nutrients (2024)
Global increases in metabolic disorders such as type 2 diabetes (T2D), especially within Asian populations, highlight the need for novel approaches to dietary intervention. The Tū Ora study previously evaluated the effects on metabolic health of including a nut product into the diet of a New Zealand cohort of Chinese participants with overweight and normoglycaemia or prediabetes through a 12-week randomised, parallel-group clinical trial. In this current study, we compared the impact of this higher-protein nut bar (HP-NB) versus a higher-carbohydrate cereal bar (HC-CB) on the faecal microbiome by employing both 16S rRNA gene amplicon and shotgun metagenomic sequencing of pre- and post-intervention pairs from 84 participants. Despite the higher fibre, protein, and unsaturated fat content of nuts, there was little difference between dietary groups in gut microbiome composition or functional potential, with the bacterial phylum Firmicutes dominating irrespective of diet. The lack of observed change suggests the dietary impact of the bars may have been insufficient to affect the gut microbiome. Manipulating the interplay between the diet, microbiome, and metabolic health may require a more substantial and/or prolonged dietary perturbation to generate an impactful modification of the gut ecosystem and its functional potential to aid in T2D risk reduction.
Keyphrases
- clinical trial
- weight loss
- physical activity
- type diabetes
- randomized controlled trial
- healthcare
- public health
- human health
- adipose tissue
- mental health
- cardiovascular disease
- amino acid
- single cell
- genome wide
- dna methylation
- climate change
- metabolic syndrome
- risk assessment
- copy number
- health information
- insulin resistance
- wastewater treatment
- phase iii
- fatty acid